Pembrolizumab monotherapy for the treatment of high-risk non-muscle-invasive bladder cancer unresponsive to BCG (KEYNOTE-057): an open-label, single-arm, multicentre, phase 2 studyArjun Vasant Balar, Ronald de Wit, Joost L. Boormans et al.|The Lancet Oncology|2021Cited by 532
Untargeted Metabolomics Revealed Potential Biomarkers of Small Yellow Follicles of Chickens during Sexual MaturationJinbo Zhao, Kun Wang, Hongbin Pan et al.|Metabolites|2023Cited by 12